Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucosylated MSCs in Osteoporosis
NCT02566655Phase 1Completed
- Sponsor
- Red de Terapia Celular
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fucosylated autologous bone marrow mesenchymal stem cells in osteoporosis, sponsored by Red de Terapia Celular. Primary endpoint: Rate of serious and non-serious adverse events related to the procedure at 24 months. Started Sep 2015; status: completed.
02
Drugs
fucosylated autologous bone marrow mesenchymal stem cells
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02566655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566655.